Skip to content
10-Q/A

Quarterly Report

Vilacto Bio Inc.

0001663577-19-000349

← back to feed
Filed
Aug 20, 2019 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2020 · Aug 19, 2019 2.14B sh
Operating Cash Flow Q1 2020 · Jun 30, 2019 −$152.99K
Operating Cash Flow Q1 2020 · Jun 30, 2018 −$101.94K
Cash And Equivalents Q1 2020 · Jun 30, 2019 $120.73K
Cash And Equivalents Q1 2020 · Mar 31, 2019 $257.22K
Cash And Equivalents Q1 2020 · Mar 31, 2018 $148.77K
Stockholders Equity Q1 2020 · Jun 30, 2019 −$2.51M
Stockholders Equity Q1 2020 · Mar 31, 2019 −$3.42M
Stockholders Equity Q1 2020 · Mar 31, 2018 −$935.91K
Current Liabilities Q1 2020 · Jun 30, 2019 $2.91M
Current Liabilities Q1 2020 · Mar 31, 2019 $3.96M
Total Liabilities Q1 2020 · Jun 30, 2019 $2.91M
Total Liabilities Q1 2020 · Mar 31, 2019 $3.96M
Current Assets Q1 2020 · Jun 30, 2019 $245.94K
Current Assets Q1 2020 · Mar 31, 2019 $376.29K
Total Assets Q1 2020 · Jun 30, 2019 $402.32K
Total Assets Q1 2020 · Mar 31, 2019 $537.67K
Sga Expense Q1 2020 · Jun 30, 2019 $140.58K
Sga Expense Q1 2020 · Jun 30, 2018 $66.59K
Net Income Q1 2020 · Jun 30, 2019 −$610.73K
Net Income Q1 2020 · Jun 30, 2019 −$8.47M
Net Income Q1 2020 · Jun 30, 2018 $52.51K
Operating Income Q1 2020 · Jun 30, 2019 −$151.85K
Operating Income Q1 2020 · Jun 30, 2018 −$117.48K
Gross Profit Q1 2020 · Jun 30, 2019 $930
Gross Profit Q1 2020 · Jun 30, 2018 $200
Cost Of Revenue Q1 2020 · Jun 30, 2019 $4.24K
Cost Of Revenue Q1 2020 · Jun 30, 2018 $230
Revenue Q1 2020 · Jun 30, 2019 $5.17K
Revenue Q1 2020 · Jun 30, 2018 $430